Rejuvenex Cream

3)
1), 2)

OTC Drug │ Advertising Review Approval No. 2025-1787-002110 │ This product may cause side effects. Please read the enclosed “Precautions for Use” carefully and consult a physician or pharmacist before use.

*Indications & Effects: Nutritional support for the skin and connective tissue, and for wounds or conditions prone to ulceration due to nutritional deficiency.

  • 1) DOT Patent, Korean Patent No. 10-0986603, 2008.
  • 2) Among sodium polydeoxyribonucleotide products listed in the Drug Safety Korea database, this is the earliest approved topical formulation (Approval Date: December 5, 2014).
  • 3) Rejuvenex cream insert paper

Rejuvenex Cream, When is it recommended?

Used for conditions where wounds occur easily or ulcers are likely to develop
due to nutritional deficiency of the skin and connective tissue. 3)

  1. 1

    Fast Regenerative Effect 4)

    PDRN promotes the release of various growth factors (VEGF, EGF, IGF, etc.),
    supporting normal skin regeneration.

  2. 2

    Helps Restore Damaged Skin 3), 4), 5)

    The tissue-regenerating properties of PDRN help support wound healing within the skin.

  3. 3

    Nutritional Support for Skin and Connective Tissue 3)

3) Rejuvenex cream insert paper
4) Squadrito, F., Bitto, A., Irrera, N., Pizzino, G., Pallio, G., Minutoli, L., & Altavilla, D. (2017). Pharmacological Activity and Clinical
Use of PDRN Frontiers in Pharmacology, 8, 224. https://doi.org/10.3389/fphar.2017.00224
5) Luigi Valdatta et al. Evaluation of the efficacy of PDRNs in the healing process of autologous skin graft donor sites:a pilot study.
Current Medical Research And Opinion. 2004;20:403 -408

DOT® PDRN

What is DOT®? 1)

DOT® stands for DNA Fragments Optimizing Technology,
a proprietary technology for producing DNA fraction mixtures.

Through patented DOT technology, PharmaResearch has developed its own process for manufacturing and commercializing DNA fragment mixtures.
(Korean Patent No. 10-0986603)

What is PDRN? 4)

PDRN, short for Polydeoxyribonucleotide,
is a DNA fragment extracted from salmon reproductive cells.

1) DOT Patent, Korean Patent No. 10-0986603, 2008.
4) Squadrito, F., Bitto, A., Irrera, N., Pizzino, G., Pallio, G., Minutoli, L., & Altavilla, D. (2017). Pharmacological Activity and Clinical Use of PDRN Frontiers in Pharmacology, 8, 224. https://doi.org/10.3389/fphar.2017.00224

Product Information

Indications & Effects Conditions prone to ulceration due to nutritional deficiency of the skin and connective tissue
(wounds, nutritional support)
Dosage & Administration Apply an appropriate amount to the affected area once or twice daily, or use as directed by a physician.
Appearance A homogeneous white cream with a characteristic odor
Ingredients
and Content		 Composition per 1 g
- Active ingredient: Sodium Polydeoxyribonucleotide (separately specified) 0.8 mg
- Preservatives: Methylparaben 1.8 mg, Propylparaben 0.2 mg
- Other excipients: Cetearyl Alcohol, Decyl Oleate, Purified Lanolin
- Solvent: Purified Water
Storage Store in a tightly closed container at room temperature (1–30°C).
Package Size 10 g / tube
* Please read the precautions for use carefully. View Precautions for Use
Rejuvenex Cream Image

Frequently Asked Questions Rejuvenex Cream

4) Squadrito, F., Bitto, A., Irrera, N., Pizzino, G., Pallio, G., Minutoli, L., & Altavilla, D. (2017). Pharmacological Activity and Clinical Use of PDRN. Frontiers in Pharmacology, 8, 224. https://doi.org/10.3389/fphar.2017.00224

MEDIA

PharmaResearch is a regenerative medicine–based
biotechnology company dedicated to improving the quality of healthy and beautiful life.

Visit PharmaResearch